Literature DB >> 23845224

Hormone receptors and ovarian cancer survival.

Charlie Gourley1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23845224     DOI: 10.1016/S1470-2045(13)70323-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Development of a multi-marker model combining HE4, CA125, progesterone, and estradiol for distinguishing benign from malignant pelvic masses in postmenopausal women.

Authors:  Pengjun Zhang; Chuanxin Wang; Liming Cheng; Peng Zhang; Lin Guo; Wanli Liu; Zhongying Zhang; Yanchun Huang; Qishui Ou; Xinyu Wen; Yaping Tian
Journal:  Tumour Biol       Date:  2015-09-09

2.  Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas.

Authors:  Aichun Wang; Chao Guo; Yunfei Sun; Lijuan Lu; Yun Wang; Qiong Wang; Yan Zhang; Hui Zhang; Li Wang; Yiqun Gu; Aijun Liu
Journal:  J Cancer       Date:  2015-04-29       Impact factor: 4.207

3.  WAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cells.

Authors:  Yao Chen; Suihai Wang; Tiancai Liu; Yingsong Wu; Ji-Liang Li; Ming Li
Journal:  J Ovarian Res       Date:  2016-02-29       Impact factor: 4.234

4.  Differential expression of estrogen receptor subtypes in ovarian high-grade serous carcinoma and clear cell carcinoma.

Authors:  Daiken Osaku; Tetsuro Oishi; Naoshi Kawamura; Yuki Iida; Hiroaki Komatsu; Akiko Kudoh; Jun Chikumi; Shinya Sato; Tasuku Harada
Journal:  Reprod Med Biol       Date:  2021-07-23

5.  Expression of CUE domain containing 2 protein in serous ovarian cancer tissue: predicting disease-free and overall survival of patients.

Authors:  Hu Lingyun; Li Ailing; Li Yali; You Yanqin; Ning Jing
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.